Relapsed acute leukemia in children

Oman Experience

Zakia Al Lamki, Yasser A. Wali, Wasifuddin M. Shah, Mathew Zachariah

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Acute leukemia (AL) is the most common malignancy in children in Oman. It accounts for over one-third of all childhood cancers, most of which (∼75%) are acute lymphoblastic leukemia (ALL). Over a decade, a total of 128 cases of childhood acute leukemia have been diagnosed and managed at Paediatric Haematology/Oncology Unit, Sultan Qaboos University Hospital, which is the national referral center of pediatric leukemia cases. A retrospective review of case notes was used to study all children with a diagnosis of acute leukemia from January 1993 to January 2003. All the cases were diagnosed using a bone marrow aspirate with morphological and immunophenotypic classification. Over this period, 24 cases relapsed. They were classified as per BFM group as "very early," "early," and "late" according to the time from diagnosis to first relapse and were divided into isolated bone marrow (BM), extramedullary site, and combined relapse. Sixteen percent of ALL cases and 58.6% of acute myeloid leukemia (AML) cases so far relapsed. Most of the AML cases relapsed very early on in treatment. Eleven patients had combined relapse in BM and extramedullary site (9 in the central nervous system, 1 in the testicles, and 1 in the eye). The overall outcome of these patients is very poor, and only 6 patients out of 24 are still alive. In conclusion, the relapse rates of childhood AL are more or less similar to those of other reports but the overall outcome is very poor. A large majority of the patients in this study are either very early or early relapsers. Future studies including genetic and molecular analysis may be able to explain the difference in clinical outcome of these relapsed AL cases.

Original languageEnglish
Pages (from-to)167-173
Number of pages7
JournalPediatric Hematology and Oncology
Volume21
Issue number2
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Oman
Bone
Leukemia
Pediatrics
Recurrence
Oncology
Bone Marrow
Neurology
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Hematology
Relapse
Testis
Molecular Biology
Neoplasms
Referral and Consultation
Central Nervous System
Childhood

Keywords

  • Acute leukemia
  • Children
  • Oman
  • Relapse

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Cancer Research
  • Management of Technology and Innovation

Cite this

Relapsed acute leukemia in children : Oman Experience. / Lamki, Zakia Al; Wali, Yasser A.; Shah, Wasifuddin M.; Zachariah, Mathew.

In: Pediatric Hematology and Oncology, Vol. 21, No. 2, 03.2004, p. 167-173.

Research output: Contribution to journalArticle

Lamki, Zakia Al ; Wali, Yasser A. ; Shah, Wasifuddin M. ; Zachariah, Mathew. / Relapsed acute leukemia in children : Oman Experience. In: Pediatric Hematology and Oncology. 2004 ; Vol. 21, No. 2. pp. 167-173.
@article{e379571dc28e4887b92a9d5ff580fd41,
title = "Relapsed acute leukemia in children: Oman Experience",
abstract = "Acute leukemia (AL) is the most common malignancy in children in Oman. It accounts for over one-third of all childhood cancers, most of which (∼75{\%}) are acute lymphoblastic leukemia (ALL). Over a decade, a total of 128 cases of childhood acute leukemia have been diagnosed and managed at Paediatric Haematology/Oncology Unit, Sultan Qaboos University Hospital, which is the national referral center of pediatric leukemia cases. A retrospective review of case notes was used to study all children with a diagnosis of acute leukemia from January 1993 to January 2003. All the cases were diagnosed using a bone marrow aspirate with morphological and immunophenotypic classification. Over this period, 24 cases relapsed. They were classified as per BFM group as {"}very early,{"} {"}early,{"} and {"}late{"} according to the time from diagnosis to first relapse and were divided into isolated bone marrow (BM), extramedullary site, and combined relapse. Sixteen percent of ALL cases and 58.6{\%} of acute myeloid leukemia (AML) cases so far relapsed. Most of the AML cases relapsed very early on in treatment. Eleven patients had combined relapse in BM and extramedullary site (9 in the central nervous system, 1 in the testicles, and 1 in the eye). The overall outcome of these patients is very poor, and only 6 patients out of 24 are still alive. In conclusion, the relapse rates of childhood AL are more or less similar to those of other reports but the overall outcome is very poor. A large majority of the patients in this study are either very early or early relapsers. Future studies including genetic and molecular analysis may be able to explain the difference in clinical outcome of these relapsed AL cases.",
keywords = "Acute leukemia, Children, Oman, Relapse",
author = "Lamki, {Zakia Al} and Wali, {Yasser A.} and Shah, {Wasifuddin M.} and Mathew Zachariah",
year = "2004",
month = "3",
doi = "10.1080/08880010490273127",
language = "English",
volume = "21",
pages = "167--173",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Relapsed acute leukemia in children

T2 - Oman Experience

AU - Lamki, Zakia Al

AU - Wali, Yasser A.

AU - Shah, Wasifuddin M.

AU - Zachariah, Mathew

PY - 2004/3

Y1 - 2004/3

N2 - Acute leukemia (AL) is the most common malignancy in children in Oman. It accounts for over one-third of all childhood cancers, most of which (∼75%) are acute lymphoblastic leukemia (ALL). Over a decade, a total of 128 cases of childhood acute leukemia have been diagnosed and managed at Paediatric Haematology/Oncology Unit, Sultan Qaboos University Hospital, which is the national referral center of pediatric leukemia cases. A retrospective review of case notes was used to study all children with a diagnosis of acute leukemia from January 1993 to January 2003. All the cases were diagnosed using a bone marrow aspirate with morphological and immunophenotypic classification. Over this period, 24 cases relapsed. They were classified as per BFM group as "very early," "early," and "late" according to the time from diagnosis to first relapse and were divided into isolated bone marrow (BM), extramedullary site, and combined relapse. Sixteen percent of ALL cases and 58.6% of acute myeloid leukemia (AML) cases so far relapsed. Most of the AML cases relapsed very early on in treatment. Eleven patients had combined relapse in BM and extramedullary site (9 in the central nervous system, 1 in the testicles, and 1 in the eye). The overall outcome of these patients is very poor, and only 6 patients out of 24 are still alive. In conclusion, the relapse rates of childhood AL are more or less similar to those of other reports but the overall outcome is very poor. A large majority of the patients in this study are either very early or early relapsers. Future studies including genetic and molecular analysis may be able to explain the difference in clinical outcome of these relapsed AL cases.

AB - Acute leukemia (AL) is the most common malignancy in children in Oman. It accounts for over one-third of all childhood cancers, most of which (∼75%) are acute lymphoblastic leukemia (ALL). Over a decade, a total of 128 cases of childhood acute leukemia have been diagnosed and managed at Paediatric Haematology/Oncology Unit, Sultan Qaboos University Hospital, which is the national referral center of pediatric leukemia cases. A retrospective review of case notes was used to study all children with a diagnosis of acute leukemia from January 1993 to January 2003. All the cases were diagnosed using a bone marrow aspirate with morphological and immunophenotypic classification. Over this period, 24 cases relapsed. They were classified as per BFM group as "very early," "early," and "late" according to the time from diagnosis to first relapse and were divided into isolated bone marrow (BM), extramedullary site, and combined relapse. Sixteen percent of ALL cases and 58.6% of acute myeloid leukemia (AML) cases so far relapsed. Most of the AML cases relapsed very early on in treatment. Eleven patients had combined relapse in BM and extramedullary site (9 in the central nervous system, 1 in the testicles, and 1 in the eye). The overall outcome of these patients is very poor, and only 6 patients out of 24 are still alive. In conclusion, the relapse rates of childhood AL are more or less similar to those of other reports but the overall outcome is very poor. A large majority of the patients in this study are either very early or early relapsers. Future studies including genetic and molecular analysis may be able to explain the difference in clinical outcome of these relapsed AL cases.

KW - Acute leukemia

KW - Children

KW - Oman

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=1542289827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542289827&partnerID=8YFLogxK

U2 - 10.1080/08880010490273127

DO - 10.1080/08880010490273127

M3 - Article

VL - 21

SP - 167

EP - 173

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 2

ER -